Cargando…
Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16
In the endeavour to develop a model for studying gene therapy of cancers associated with human papillomaviruses (HPVs), mouse cells were transformed with the HPV type 16 (HPV16) and activated H-ras oncogenes. This was done by contransfection of plasmid p16HHMo, carrying the HPV16 E6/E7 oncogenes, an...
Autores principales: | Šmahel, M, Sobotková, E, Bubeník, J, Šímová, J, Žák, R, Ludvíková, V, Hájková, R, Kovařík, J, Jelínek, F, Povýšil, C, Marinov, J, Vonka, V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363731/ https://www.ncbi.nlm.nih.gov/pubmed/11225590 http://dx.doi.org/10.1054/bjoc.2000.1615 |
Ejemplares similares
-
Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status
por: Šímová, J, et al.
Publicado: (2011) -
PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression
por: Šmahel, Michal
Publicado: (2017) -
Systemic Administration of CpG Oligodeoxynucleotide and Levamisole as Adjuvants for Gene-Gun-Delivered Antitumor DNA Vaccines
por: Šmahel, Michal, et al.
Publicado: (2011) -
Superantigen and class II MHC molecules.
por: Kim, J.
Publicado: (1995) -
Electrophoretic mobility of mouse T-cell hybrids.
por: Bubeník, J., et al.
Publicado: (1981)